Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended |
Mar. 31, 2020 | Mar. 31, 2019 |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Document Period End Date | | Mar. 31, 2020 | | |
Stock-Based Compensation Expenses | | $ 40,072 | | $ 39,087 |
Common Shares Available for Grant | | 6,700,000 | | |
Stock Options And SARs | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 14,100 | | $ 13,900 |
Unrecognized compensation expense | | $ 74,900 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 8 months 12 days | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | |
Weighted Average Fair Value of Grants (price per share) | | $ 19.67 | | $ 27.19 |
Expected Volatility (in hundredths) | | 33.43% | | 31.81% |
Risk-Free Interest Rate (in hundredths) | | 1.43% | | 2.51% |
Dividend Yield (in hundredths) | | 1.60% | | 0.88% |
Expected Life (in years) | | 5 years | | 5 years |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | | | | |
Outstanding at January 1 (in shares) | | 9,395,000 | | 8,310,000 |
Exercised (1) (in shares) | [1] | (23,000) | | (43,000) |
Granted (in shares) | | 9,000 | | 17,000 |
Forfeited (in shares) | | (47,000) | | (48,000) |
Outstanding at March 31 (2) (in shares) | [2] | 9,334,000 | | 8,236,000 |
Stock Options and SARs Vested or Expected to Vest (3) (in shares) | [3] | 8,998,000 | | 7,892,000 |
Stock Options and SARs Exercisable at March 31 (4) (in shares) | [4] | 5,249,000 | | 3,997,000 |
Intrinsic Value of Stock Options/SARs Exercised | [1] | $ 400 | | $ 1,100 |
Intrinsic Value of Stock Options/SARs Outstanding | [2] | $ 0 | | $ 51,800 |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) | [2] | 4 years | | 4 years 2 months 12 days |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | [3] | $ 0 | | $ 51,100 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | [3] | 4 years | | 4 years 1 month 6 days |
Aggregate Intrinsic Value for Exercisable Units | [4] | $ 0 | | $ 43,100 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | [4] | 2 years 9 months 18 days | | 2 years 8 months 12 days |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | |
Outstanding at January 1 (price per share) | | $ 94.53 | | $ 96.90 |
Granted (price per share) | | 75.44 | | 96.67 |
Exercised (1) (price per share) | [1] | 69.59 | | 69.94 |
Forfeited (price per share) | | 96.81 | | 105.43 |
Outstanding at March 31 (2) (price per share) | [2] | 94.56 | | 96.99 |
Vested or Expected to Vest (3) (price per share) | [3] | 94.55 | | 96.53 |
Exercisable at March 31 (4) (price per share) | [4] | 94.33 | | 86.25 |
ESPP | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | |
Weighted Average Fair Value of Grants (price per share) | | $ 20.80 | | $ 22.98 |
Expected Volatility (in hundredths) | | 35.24% | | 36.31% |
Risk-Free Interest Rate (in hundredths) | | 1.56% | | 2.48% |
Dividend Yield (in hundredths) | | 1.56% | | 0.83% |
Expected Life (in years) | | 15 days | | 15 days |
Restricted Stock And Restricted Stock Units | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Unrecognized compensation expense | | $ 177,800 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 7 months 6 days | | |
Intrinsic value released during the year | [5] | $ 11,000 | | $ 22,000 |
Aggregate intrinsic value of stock and units outstanding | [6] | 154,500 | | 370,200 |
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward] | | | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 24,800 | | $ 23,300 |
Outstanding at January 1 (in shares) | | 4,546,000 | | 3,792,000 |
Granted (in shares) | | 26,000 | | 371,000 |
Released (1) (in shares) | [5] | (259,000) | | (247,000) |
Forfeited (in shares) | | (11,000) | | (26,000) |
Outstanding at March 31 (2) (in shares) | [6] | 4,302,000 | | 3,890,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | |
Outstanding at January 1 (price per share) | | $ 90.16 | | $ 96.64 |
Granted (price per share) | | 63.48 | | 96.72 |
Released (1) (price per share) | [5] | 88.19 | | 93.37 |
Forfeited (price per share) | | 89.86 | | 98.11 |
Outstanding at March 31 (2) (price per share) | [6] | $ 90.12 | | $ 96.85 |
Performance Unit | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 1,200 | | $ 1,900 |
Unrecognized compensation expense | | $ 7,500 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 2 years | | |
Intrinsic value released during the year | [7] | $ 9,000 | | 0 |
Aggregate intrinsic value of stock and units outstanding | [8] | $ 19,500 | | $ 58,100 |
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward] | | | | |
Outstanding at January 1 (in shares) | | 598 | | 539 |
Granted (in shares) | | 0 | | 0 |
Granted for Performance Multiple (1) | [9] | 66 | | 72 |
Released (1) (in shares) | [7] | (121) | | 0 |
Forfeited (in shares) | | 0 | | 0 |
Outstanding at March 31 (2) (in shares) | [8] | 543 | [10] | 611 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | |
Outstanding at January 1 (price per share) | | $ 92.19 | | $ 101.53 |
Granted (price per share) | | 0 | | 0 |
Granted for Performance Multiple (1) (in dollars per share) | [9] | 100.95 | | 69.43 |
Released (1) (price per share) | [7] | 104.69 | | 0 |
Forfeited (price per share) | | 0 | | 0 |
Outstanding at March 31 (2) (price per share) | [8] | $ 90.48 | | $ 97.75 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | |
Performance Period for Performance Units and Shares | | 3 years | | |
Minimum Performance Multiple at the Completion of the Performance Period | | 0.00% | | |
Performance Multiple Applied at the Completion Period | [9] | 150.00% | | |
Performance Multiple Applied at the Completion Period | [9] | 200.00% | | |
Minimum Performance Units and Stock Allowed to be Outstanding | [10] | 179 | | |
Maximum Performance Units and Stock Allowed to be Outstanding | [10] | 907 | | |
Lease and Well | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 15,100 | | $ 13,700 |
Gathering and Processing Costs | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | 300 | | 200 |
Exploration Costs | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | 7,200 | | 6,500 |
General and Administrative | | | | |
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items] | | | | |
Stock-Based Compensation Expenses | | $ 17,500 | | $ 18,700 |
| |
[1] | The total intrinsic value of stock options/SARs exercised during the three months ended March 31, 2020 and 2019 was $0.4 million and $1.1 million , respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at March 31, 2020 and 2019 was zero and $51.8 million , respectively. At March 31, 2020 and 2019 , the weighted average remaining contractual life was 4.0 years and 4.2 years , respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2020 and 2019 was zero and $51.1 million , respectively. At March 31, 2020 and 2019 , the weighted average remaining contractual life was 4.0 years and 4.1 years , respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at March 31, 2020 and 2019 was zero and $43.1 million , respectively. At March 31, 2020 and 2019 , the weighted average remaining contractual life was 2.8 years and 2.7 years , respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released during the three months ended March 31, 2020 and 2019 was $11.0 million and $22.0 million , respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2020 and 2019 was $154.5 million and $370.2 million , respectively. | |
[7] | The total intrinsic value of performance units released during the three months ended March 31, 2020 was $9.0 million . The intrinsic value is based upon the closing price of EOG's common stock on the date the performance units are released. There were no performance units released during the three months ended March 31, 2019. | |
[8] | The total intrinsic value of performance units outstanding at March 31, 2020 and 2019 was approximately $19.5 million and $58.1 million , respectively. | |
[9] | Upon completion of the Performance Period for the performance units granted in 2016 and 2015, a performance multiple of 150% and 200% , respectively, was applied to each of the grants resulting in additional grants of performance units in February 2020 and February 2019, respectively. | |
[10] | Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 179 and a maximum of 907 performance units could be outstanding. | |